New York, June 27, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Transdermal Medical Patch Market Forecast to 2028 - COVID-19 Impact ...

Dublin, March 25, 2024 (GLOBE NEWSWIRE) -- The "Global Transdermal Medical Patch Market: Analysis By Type, By Application, By Distribution Channel, By Region Size & Forecast to 2029" report has been ...

Nutriband files provisional patent application to enhance its AVERSA™ transdermal abuse deterrent technology being developed for patches containing opioids and stimulants with a potential for abuse.

The Transdermal Contraceptive Patch Market is a rapidly evolving segment within the broader contraceptive industry, offering a convenient and effective method of birth control. These patches are ...

TOKYO, March 31, 2025 /PRNewswire/ -- Luye Pharma Group today announced that marketing approval for its innovative formulation Rivastigmine Twice Weekly Transdermal Patch has been granted by the ...

Private Placement of $8.4 million has closed and will fund the commercial development of lead product AVERSA Fentanyl to NDA filing Nutriband working to complete the commercial scale-up prior to ...